心肌梗死后患者血管紧张素转换酶抑制剂应给予多长时间:HOPE试验的意义

{"title":"心肌梗死后患者血管紧张素转换酶抑制剂应给予多长时间:HOPE试验的意义","authors":"V. Bonarjee, K. Dickstein","doi":"10.1186/cvm-2-4-151","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"62 1","pages":"151 - 155"},"PeriodicalIF":0.0000,"publicationDate":"2001-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial\",\"authors\":\"V. Bonarjee, K. Dickstein\",\"doi\":\"10.1186/cvm-2-4-151\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":53230,\"journal\":{\"name\":\"Current Controlled Trials in Cardiovascular Medicine\",\"volume\":\"62 1\",\"pages\":\"151 - 155\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Controlled Trials in Cardiovascular Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/cvm-2-4-151\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Controlled Trials in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/cvm-2-4-151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}